2-Amino-9H-pyrido [2,3-b]indole (AαC) is the most abundant carcinogenic heterocyclic aromatic amine (HAA) formed in mainstream tobacco smoke. AαC is a liver carcinogen in rodents, but its carcinogenic potential in humans is not known. To obtain a better understanding of the genotoxicity of AαC in humans, we have investigated its metabolism and its ability to form DNA adducts in human hepatocytes. Primary human hepatocytes were treated with AαC at doses ranging from 0.1 to 50 µM and the metabolites were characterized by UPLC/ ion trap multistage mass spectrometry (UPLC/MS n ). Six major metabolites were identified: a ring-oxidized doubly conjugated metabolite, 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 and reveal the importance of N-acetylation and glucuronidation in metabolism of AαC. P450
INTRODUCTION
Epidemiologic studies conducted over the past two decades have consistently shown that smoking is a risk factor for liver and gastrointestinal tract cancer. [1] [2] [3] Cigarette smoking is a prominent source of exposure to a number of genotoxicants including nitrosamines, aromatic amines, polycyclic aromatic hydrocarbons, and heterocyclic aromatic amines (HAA). 4 HAA are also formed in well-done cooked meat, poultry and fish, 5 and some occur in diesel gas exhaust. these three chemicals are recognized as human carcinogens.
3,14
AαC has been detected in urine of smokers of the Shanghai Cohort study. 15 The urinary levels were positively correlated to the number of cigarettes smoked per day. A similar finding was reported in Zengshu, China, where AαC was present at higher levels in the urine of smokers than nonsmokers. 16 Recently, a tobacco smoking cessation study conducted in the United States revealed that AαC was present in urine during the smoking phase in greater than 90% of the subjects, and the geometric mean urinary level of AαC decreased by 87% six weeks after cessation of tobacco usage. 17 These urinary biomarker data demonstrate that tobacco smoking is a significant source of AαC exposure. The data reported in the literature on urinary level of AαC in human are restricted to two reports where the mean level of AαC in urine of subjects who smoked greater than 20 cigarette per day range between 12 and 35 pg/mg creatinine.
15-17
AαC induces liver and blood vessel tumors in CDF1 mice, 5,18 it induces lacI transgene mutations in the colon of C57BL/6 mice, 19 and aberrant crypt foci, an early biomarker of colon neoplasia, in Big Blue mice. 20 However, the genotoxicity of AαC remains unknown in humans and only few reports have been reported on the genotoxicity of AαC in vitro in human cells. AαC is genotoxic in human lymphoblastoid cells (MLC-5) 21 and in peripheral blood lymphocytes cells, when assessed the by the comet and micronucleus assays. 22 We also showed that AαC forms high and persistent levels of DNA adducts in primary human hepatocytes. 23, 24 The major DNA adduct formed by AαC is N-(deoxyguanosin-8-yl)-2-amino-9H-pyrido[2,3-b]indole (dG-C8-AαC) 25, 26 which is regarded as a mutagenic lesion. 27 The levels of dG-C8-AαC formed in primary human hepatocytes were greater than those dG-C8 AαC to unstable esters, which undergo heterolytic cleavage to form the presumed short-lived nitrenium ion, which covalently adducts to DNA. 30 In contrast to the NAT and SULT enzymatic pathways of bioactivation, the UDP-Glucuronosyltrasferases (UGT) are largely viewed as conjugation pathways that lead to detoxication. 31 UGT-mediated conjugation of glucuronic acid (Gluc) to the exocyclic amino groups of HAA or N-hydroxylated HAA is a detoxification pathway for HAA. [31] [32] [33] However, we discovered that the UGT also catalyze the O-glucuronidation of HONH-AαC to form the AαC-HN 2 -O-Gluc conjugate, a reactive metabolite that contributes to the genotoxicity of AαC. 34 The abundance of AαC in tobacco smoke and its propensity to undergo bioactivation by hepatic enzymes provides a plausible biochemical mechanism that may explain how AαC can induce DNA damage and play a role in the development of liver and digestive tract cancers in smokers. 1, 35, 36 However stable biomarkers must be developed and implemented in molecular epidemiological studies designed to assess the role of chemical exposures to AαC in cancer risk. For this purpose, a better understanding of the metabolism of AαC is required.
Studies have been devoted to the metabolism of AαC in vitro with hepatic human liver microsomes or recombinant human P450s 29,30,37-39 and in vivo mainly in rats 26,37,40 and mice. 41 However, knowledge about the major metabolic pathways of AαC and the key enzymes involved in bioactivation of this carcinogen in liver and extrahepatic tissues of humans are limited. There is only one study reported the metabolism of AαC in human hepatocarcinoma cell line HepG2. 40 This cell line is not fully metabolically competent since it does not express some important metabolism enzymes such as UGT. 40 In contrast, primary human hepatocytes are the gold standard to investigate different pathways of carcinogen metabolism, since this cell model retains liver function for at least seven days and expresses phase I and phase II enzymes as well as cofactors at physiological concentrations. 42 The aim of our study was to characterize the major metabolites of AαC formed in human liver using primary cultured human hepatocytes. The metabolites were characterized by UPLC/MS n in conjunction with HPLC and ultraviolet detection, and by treatment with the deconjugation enzymes arylsulfatase and β-glucuronidase. Our findings show that AαC undergoes multiple pathways of metabolism that include N 2 -acetylation, N 2 -glucuronidation, as well as ring-oxidation at the C-3 and C-6 atoms of the heterocyclic ring of AαC. The 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 streptomycin (10 µg/mL) (Life technologies) and 10% fetal calf serum (v/v) (Life technologies). After 18 h of cell seeding, the media was replaced with cell media lacking fetal calf serum and containing hydrocortisone hemisuccinate ( were measured in all primary cultured hepatocytes used in this study as described previously. 24 The reaction rates were linear over the reaction time and proportional to protein concentration.
46
Samples preparation and HPLC analysis of the major metabolites of AαC. (4.6 x 250 mm, 5 µm particle size) from Thermo Scientific (Bellefonte, PA). The chromatography commenced isocratically at 95% A solvent (20 mM ammonium acetate and 5% acetonitrile) for 10 min, followed by a linear gradient over 20 min to 50% B (acetonitrile)
at a flow rate of 1 mL/min. The column was then washed with 100% acetonitrile and reequilibrated at starting solvent conditions. Once collected, the metabolites were evaporated to dryness and stored at -80 °C until LC/MS analysis. The enzymes solutions and buffers were purged with argon before use, and the incubations were conducted in tightly closed Eppendorf tubes to minimize oxidation of the deconjugated metabolites. The hydrolysis was terminated by the addition of 1 volume of ice-cold methanol.
The precipitated proteins were removed by centrifugation and the supernatants were analyzed by HPLC as described above. The proposed N-acetylated ring-oxidized AαC Gluc conjugate (N 2 -acetyl-AαC-6-O-Gluc) was subjected to enzymatic hydrolysis by β-glucuronidase under the same conditions as described above, followed by acid hydrolysis (0.1 M HCl) for 3 h at 60 °C. After addition of 1 volume of ice-cold methanol and incubation for 5 min on ice, the precipitated protein was eliminated by centrifugation. The supernatant was dried and resuspended in HPLC grade water. The hydrolysis products were analyzed by HPLC as described above. The UV spectra of each hydrolysis products was compared to those spectra of AαC-6-OH and AαC-3-OH, which were produced with human liver microsome as previously reported.
34,41
Solid-phase extraction (SPE) of hepatocyte metabolites for UPLC-ESI-MS n . The cell media containing AαC metabolites were processed by SPE using Oasis HLB 1 cc (30 mg) cartridge (Waters, Milford, MA, USA), prior to UPLC-ESI-MS n analysis. After the conditioning the cartridge with 1 mL of methanol, followed by 1 mL of LC/MS grade water, the cell media (100-500 µL) diluted in 2 mM ammonium acetate (added up to 1 mL) were loaded in the cartridge. The cartridge was washed with 1 mL of 2 mM ammonium acetate, and metabolites were eluted with 1 mL of methanol. The eluates were evaporated to dryness by vacuum centrifugation at 42 °C. The residues were dissolved in mobile phase buffer (2 mM ammonium acetate). were added and the mixture was incubated for 1 h at 37 °C. The DNA was purified by the phenol/chloroform extraction, followed by precipitation with ethanol. 47 DNA was resuspended in 200 µL of sterile water and quantified with a NanoDrop 1000
UPLC-ESI-MS
Spectrophotometer (Thermo Fisher Scientific). Each DNA sample was spiked with isotopically labeled internal standards at a level of 1 adduct per 10 7 bases. DNA digestion was performed in 5 mM Bis-Tris-HCl buffer (pH 7.1). DNA was incubated for 3.5 h with DNase I and Nuclease P1 at 37 °C followed by 18 h incubation with alkaline phosphatase and phosphodiesterase at 37 °C. 48 After vacuum centrifugation to the dryness, digested DNA was resuspended in 30 µL of 1:1 water/DMSO (v/v) and sonicated for 5 min. Samples were then centrifuge for 5 min at 21 000 g and the supernatant was transferred to LC vials. showed that M2 co-eluted with AαC-6-OH and displayed an UV spectrum identical to that of AαC-6-OH, whereas the hydrolysis product of M3 co-eluted with AαC-3-OH and exhibited the same UV spectrum as AαC-3-OH ( Figure S1 ). The AαC-6-OH and AαC-3-OH reference compounds produced by human liver microsomes were characterized by 1 H-NMR, which unambiguously identified the sites of ring-oxidation of AαC. 17, 34 Taken together these results lead us to identify M2 as AαC-6-O-Gluc and M3 as AαC-3-O-Gluc.
UPLC/MS

RESULTS
Identification of the major metabolites of Aα
As was observed for the O-Gluc conjugates, the isomeric sulfate conjugates can be distinguished by their product ion spectra. The product ion spectrum of AαC-6-O-SO 3 H (M6) as N 2 -acetyl-AαC-6-O-Gluc was determined by comparing the UV spectrum of hydrolysis product to those UV spectra of AαC-6-OH and AαC-3-OH. The N 2 -acetyl-AαC-6-O-Gluc hydrolysis product (enzymatic hydrolysis using β-glucuronidase followed by acid hydrolysis) co-eluted and exhibited an UV spectrum identical to that of AαC-6-OH, whereas the UV spectrum and retention time of AαC-3-OH were different. These data confirm the identification of M1 as N 2 -acetyl-AαC-6-O-Gluc ( Figure 3B ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 In addition to these fully characterized metabolites, we observed the formation of several other minor metabolites, which are isomers of those characterized above and include two N 2 -acetyl-AαC-O-Gluc, one N 2 -acetyl-AαC-O-SO 3 H, and one AαC-N-Gluc. 1A2 inhibitor. 43 In our experimental conditions, we observe that 24 h of treatment with 5 µM of furafylline leads to more than 80% decrease of P450 1A2 activity (date not shown). As shown in Figure 7 , the pre-incubation of human hepatocytes with furafylline resulted in a strong decrease in the levels of AαC-HN 2 -O-Gluc with a concomitant increase in the amount 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 60
Characterization of minor metabolites of Aα
Aα
DISCUSSION
The aim of this study was to characterize the major metabolites of AαC formed in primary human hepatocytes using UPLC/MS n . Our data demonstrate that AαC is subjected to direct 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 metabolism by N 2 -acetylation and oxidation, we have not yet detected DNA adducts of AαC that possesses an N-acetyl group (unpublished observations, R. Turesky) as was reported for the structurally related aromatic amine, 2-aminofluorene. 54, 55 There are large interspecies differences in metabolism of AαC in human hepatocytes compared to those previously reported in vivo in rats. 40 The four major metabolites of AαC identified in the bile and urine of adult male Sprague-Dawley rats treated intravenously with
acetyl-AαC-3-O-Gluc. 40 The latter three metabolites were produced in relatively minor amounts in primary human hepatocytes. This discrepancy may be explained, in part by the different catalytic activities and regioselectivity of human and rat enzymes orthologues toward this procarcinogen. We previously reported interspecies differences in metabolism of two other HAA, PhIP and MeIQx in rodent and human hepatocytes. 52, 53 Indeed, the catalytic activity of human P450 1A2 was 9 to 11 fold higher than rat P450 1A2 in the N-oxidation of MeIQx and PhIP, 53, 56 and human P450 1A2 catalyzed the N-oxidation as the major pathway of metabolism whereas ring oxidation of these HAA was negligible. 52, 53, 57, 58 The biotransformation of AαC was also previously investigated in the human liver HepG2 cell line, where four major metabolites were identified: AαC-3-O-SO 3 H, AαC-6-O-SO 3 H, N 2 -acetyl-AαC-6-O-SO 3 H and N 2 -acetyl-AαC. 40 The absence of Gluc metabolites is not surprising since this cell line is devoid of UGT. 40, 59 Taken together, these metabolic data show that rats and HepG2 cell lines do not fully capture the metabolism of AαC that occurs in human hepatocytes. Recently, some oxidative products of AαC, including AαC-3-O-SO 3 H, were detected in plasma of liver specific P-450 reductase null mice, suggesting that a non-hepatic P450 enzymes catalysed oxidation of AαC in the mouse model. 41 The level of DNA adduct formation of AαC in liver was also unaffected in the liver specific P-450 reductase null mice treated with high doses of AαC. 43 Our data show that the contribution of non-P450 oxidases to the metabolism of AαC and bioactivation in human hepatocytes is minor.
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